Biological production method of L-aspartic acid
Through the immobilization treatment of sodium alginate, glutaraldehyde and calcium chloride and the combination of modified crosslinked dextran gel filtration column, the problem of low impurity removal efficiency in L-aspartic acid production is solved, and the problem of low impurity removal in L-aspartic acid production is achieved. The production of L-aspartic acid with high purity and high yield improves the safety and biological activity of the product.
Patent Information
- Application Number
- CN202411465110.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-21
- Publication Date
- 2024-11-19
AI Technical Summary
The impurity removal efficiency in the existing L-aspartic acid production methods is low, especially metal impurities have negative impacts on product purity and safety, and the yield is low.
Immobilization treatment was performed using sodium alginate, glutaraldehyde and calcium chloride, combined with a modified crosslinked dextran gel filtration column for purification, using the coordination of nickel ions and carboxylic acid groups and the quaternary ammonium salt. Charge interaction enables efficient removal of impurities and improves yields.
It significantly improves the purity and yield of L-aspartic acid, effectively removes impurities, especially metal impurities, and enhances the biological activity and safety of the product.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of L-aspartic acid production, in particular to a biological production method of L-aspartic acid. Background Art
[0002] L-aspartic acid, also known as L-aspartic acid, is an α-amino acid and one of the 20 natural amino acids that make up protein. In medicine, L-aspartic acid can be used to treat heart disease, liver disease and high blood pressure, and can also be used as an ammonia detoxifier, liver function promoter and fatigue recovery agent; in the food industry, L-aspartic acid is a good nutritional supplement that can be added to various refreshing drinks and is also the main raw material for producing the sweetener aspartame; in the chemical industry, L-aspartic acid is the precursor of the synthetic polymer material polyaspartic acid.
[0003] Chinese patent application with publication number CN117757866A discloses a method for producing L-aspartic acid using maleic acid by immobilizing genetically engineered bacteria that co-express maleic cis-trans isomerase and aspartase. The genetically engineered bacteria are first cultured and amplified, and then immobilized. The immobilized bacteria are then used to undergo a conversion reaction with maleic acid to produce L-aspartic acid. After the reaction is completed, the immobilized cells can be recovered by filtration for the next batch of reactions.
[0004] The Chinese patent application with publication number CN117820148A discloses a method for extracting L-aspartic acid, comprising: passing decolorized L-aspartic acid ammonium conversion liquid through a deamination resin column, maintaining the temperature of the deamination resin column at 88-95°C, adsorbing ammonium ions in the conversion liquid through ion exchange to obtain a column liquid and a saturated resin; regenerating the saturated resin using cis-acid water with a mass percentage of maleic acid of 40-45%, and washing with water to obtain a regenerated deamination resin column, a regenerated liquid and a washing water; adding cis-acid water with a mass percentage of maleic acid of 40-45% to the column liquid at 85-95°C to adjust the pH to 3.5-3.8; cooling, crystallizing, filtering to obtain L-aspartic acid crystals and a crystallization mother liquor; combining the regenerated liquid and the washing water with the crystallization mother liquor, concentrating them and returning them to the previous batching process for use.
[0005] The Chinese patent application with publication number CN117004662A discloses a large-scale production method for preparing L-aspartic acid from maleic acid by dual enzyme coupling catalysis. First, a recombinant Escherichia coli having both maleate cis-trans isomerase encoding genes and L-aspartate lyase encoding genes is constructed, and then the recombinant Escherichia coli whole cells are used to catalyze the addition of maleic acid to generate L-aspartic acid.
[0006] In the production process of L-aspartic acid, the impurities that need to be removed mainly include the following categories: Biological impurities: This includes dead cells, cell fragments, proteins, nucleic acids and other biological macromolecules in the culture medium, as well as possible microbial contamination. Organic impurities: These are mainly organic compounds produced by microbial metabolism, such as sugars, lipids, other amino acids and metabolic intermediates. Inorganic impurities: Include metal ions, salts, and other inorganic substances. Particulate impurities: May be solid particles introduced from raw materials or production processes. Metal impurities may have a negative impact on the purity and quality of the final product, and the presence of metal impurities may affect the biological activity or safety of the product. In addition, metal ions may also catalyze undesirable chemical reactions, resulting in product degradation or the formation of impure by-products.
[0007] The L-aspartic acid prepared by the above patents has a low content and the yield needs to be further improved. Summary of the invention
[0008] In order to solve the above problems, the present invention provides a biological production method of L-aspartic acid, the operation steps of which are as follows: S1: Inoculate the L-aspartate lyase strain into the culture medium and culture it on a shaker for 6-10 hours as the first generation, and continue to culture the second generation under the same conditions; S2: Transfer the inoculation amount to the fermentation medium at 3-8% of the volume of the transferred medium, culture on a shaker for 2-4 hours, then lower the temperature to 30°C and continue culturing for 5-8 hours, centrifuge for 5-10 minutes, discard the supernatant, and obtain the bacterial cells; S3: Take 1-5 parts of the centrifuged bacteria and add 200-250 parts of water to obtain a high-purity bacterial solution; S4: Take 5-10 parts of high-purity bacterial liquid, add 5-10 parts of sodium alginate and 0.1-0.5 parts of glutaraldehyde, mix well, slowly drip into 10-20 parts of CaCl2 solution, react at 30-40°C for 150-180 minutes to form gel beads, filter out the beads, wash twice with sodium chloride saline to obtain immobilized cells; S5: Take 0.1-1 parts of immobilized cells and 5-10 parts of fumaric acid with a mass concentration of 260-300 g / L, adjust the pH to 7-8, and oscillate on a shaker at a constant temperature for 150-180 minutes to obtain L-aspartic acid; further purify through a modified cross-linked dextran gel filtration column with a flow rate of 0.5-2 BV / h to obtain high-purity L-aspartic acid.
[0009] Furthermore, the shaking culture temperature of the shaker is 35-37°C and the rotation speed is 150-180r / min.
[0010] Furthermore, the centrifugal speed is 4500-5000r / min.
[0011] Furthermore, the preparation method of the culture medium is: Dissolve 0.1-1 parts of yeast powder, 0.2-2 parts of peptone, and 0.2-2 parts of NaCl in 100-200 parts of pure water, adjust the pH to neutral, and sterilize for later use.
[0012] Furthermore, the preparation method of the fermentation medium is: Dissolve 1-5 parts of yeast powder, 5-10 parts of peptone, 1-5 parts of NaCl, and 1-5 parts of lactose in 800-1000 parts of pure water, adjust the pH to neutral, and sterilize for later use.
[0013] Furthermore, the preparation process of the modified cross-linked dextran gel in S5 is as follows: First, 40-100 portions of washed cross-linked dextran gel G-75 are taken and placed in a low-temperature plasma treatment device; at this stage, a mixed vapor of mercaptoethanol vapor and nickel acetylacetone vapor is selected as a carrier gas, the gas flow rate is controlled at 30-50 ml / min, and the power is adjusted to 100-200 watts. Under such conditions, the gel is subjected to plasma treatment for 10-30 minutes; Secondly, a mixed vapor of ammonia, dimethyldiallylammonium chloride and nickel acetylacetonate is introduced, the air flow rate is adjusted to 15-25 ml / min, and the plasma treatment is continued for 10-30 minutes; after the treatment is completed, the sample is vacuum dried at 60-70°C to obtain a modified cross-linked dextran gel.
[0014] Furthermore, the volume ratio of the mixed steam of ammonia and dimethyldiallylammonium chloride is 1:(0.2-0.5).
[0015] Furthermore, the mixed steam of the mercaptoethanol vapor and the nickel acetylacetone vapor has a volume ratio of 1:(0.003-0.05).
[0016] Compared with the prior art, the biological production method of L-aspartic acid of the present invention has the following beneficial effects: 1. The present invention uses sodium alginate as an embedding agent, glutaraldehyde as a cross-linking agent and calcium chloride as a filler to immobilize aspartase genetic engineering bacteria, fixes aspartase genetic engineering bacteria by an embedding method, and uses fumaric acid and ammonia water as substrates to prepare L-aspartic acid; the L-aspartic acid prepared by the present invention has the advantages of high content and high conversion rate.
[0017] 2. Coordination of nickel with carboxylic acid groups and its effect on the purification of L-aspartic acid: Mechanism of coordination bond formation: Nickel ions have empty d orbitals and can act as electron docking acceptors; while the oxygen atom on the carboxylic acid group in L-aspartic acid has a lone pair of electrons and can act as an electron pair donor; therefore, a stable coordination bond is easily formed between the two. This selective chemical force is the basis for its ability to effectively separate compounds with carboxylic acid groups.
[0018] Effect of removing impurities: In the production process of L-aspartic acid, other amino acids or derivatives are often accompanied by impurities; if these impurities contain carboxylic acid groups, they can be fixed on the gel through coordination with nickel ions, thereby achieving efficient separation from L-aspartic acid.
[0019] 3. The effect of introducing quaternary ammonium salt on enhancing adsorption capacity: Charge interaction: Quaternary ammonium salt is a positively charged group, which can have a strong charge interaction with negatively charged impurities; this charge-based adsorption is usually stronger than physical adsorption or hydrophobic effect, and can effectively improve the adsorption performance of the material.
[0020] Mechanism of removing histidine-containing protein impurities: Histidine residues carry a positive charge at physiological pH. The positive charge of quaternary ammonium salts gives the gel a special affinity for these protein impurities, thereby selectively adsorbing and removing such impurities from the mixture. DETAILED DESCRIPTION
[0021] In order to further explain the technical means and effects adopted by the present invention to achieve the predetermined invention purpose, the specific implementation method, structure, characteristics and effects of the present invention are described in detail below in combination with the preferred embodiments.
[0022] 1. Determination of L-aspartic acid content: UV spectrophotometer method is used for detection; 2. L-aspartic acid yield = actual L-aspartic acid production / theoretical L-aspartic acid production × 100%.
[0023] Embodiment 1: The biological production method of L-aspartic acid, its operation steps are: S1: Inoculate the L-aspartate lyase strain into the culture medium and culture it on a shaker for 6 hours as the first generation, and continue to culture the second generation under the same conditions; S2: Transfer the inoculation volume to the fermentation medium at 3% of the volume of the transferred medium, shake and culture for 2 h, then lower the temperature to 30°C and continue culturing for 5 h. Centrifuge for 5 min, discard the supernatant, and obtain the bacterial cells. S3: Take 1g of the centrifuged bacteria and add 200g of water to obtain a high-purity bacterial solution; S4: Take 5g of high-purity bacterial liquid, add 5g of sodium alginate and 0.1g of glutaraldehyde, mix well, slowly drip into 10g of CaCl2 solution, react at 30℃ for 150min to form gel beads, filter out the beads, wash twice with sodium chloride saline to obtain immobilized cells; S5: Take 0.1g of immobilized cells and 5g of fumaric acid with a mass concentration of 260g / L, adjust the pH to 7, and oscillate on a shaker at a constant temperature for 150min to obtain L-aspartic acid; further purify through a modified cross-linked dextran gel filtration column with a flow rate of 0.5BV / h to obtain high-purity L-aspartic acid.
[0024] The shaking culture temperature of the shaking table is 35°C and the rotation speed is 150r / min.
[0025] The centrifugal speed is 4500r / min.
[0026] The preparation method of the culture medium is: Dissolve 0.1g yeast powder, 0.2g peptone and 0.2g NaCl in 100g pure water, adjust the pH to neutral, and sterilize for later use.
[0027] The preparation method of the fermentation medium is as follows: Dissolve 1g yeast powder, 5g peptone, 1g NaCl, and 1g lactose in 800g pure water, adjust the pH to neutral, and sterilize for later use.
[0028] The preparation process of the modified cross-linked dextran gel in S5 is as follows: First, 40 g of washed cross-linked dextran gel G-75 was taken and placed in a low-temperature plasma treatment device; at this stage, a mixed vapor of mercaptoethanol vapor and nickel acetylacetone vapor was selected as the carrier gas, the gas flow rate was controlled at 30 ml / min, and the power was adjusted to 100 watts. Under such conditions, the gel was plasma treated for 10 minutes; Secondly, a mixed vapor of ammonia, dimethyldiallylammonium chloride and nickel acetylacetonate was introduced, the air flow rate was adjusted to 15 ml / min, and the plasma treatment was continued for 10 minutes; after the treatment was completed, the sample was vacuum dried at 60°C to obtain a modified cross-linked dextran gel.
[0029] The volume ratio of the mixed steam of ammonia and dimethyldiallylammonium chloride is 1:0.2.
[0030] The mixed steam of the mercaptoethanol steam and the nickel acetylacetone steam has a volume ratio of 1:0.003.
[0031] Embodiment 2: The biological production method of L-aspartic acid, its operation steps are: S1: Inoculate the L-aspartate lyase strain into the culture medium and culture it on a shaker for 7 hours as the first generation, and continue to culture the second generation under the same conditions; S2: Transfer the inoculation volume to the fermentation medium at 4% of the volume of the transferred medium, shake and culture for 3 hours, then lower the temperature to 30°C and continue culturing for 6 hours. Centrifuge for 6 minutes, discard the supernatant, and obtain the bacterial cells. S3: Take 2 g of the centrifuged bacteria and add 210 g of water to obtain a highly pure bacterial solution; S4: Take 6g of high-purity bacterial liquid, add 6g of sodium alginate and 0.2g of glutaraldehyde, mix well, slowly drip into 13g of CaCl2 solution, react at 35℃ for 160min to form gel beads, filter out the beads, wash twice with sodium chloride saline to obtain immobilized cells; S5: Take 0.5g of immobilized cells and 6g of fumaric acid with a mass concentration of 270g / L, adjust the pH to 7, and oscillate on a shaker at a constant temperature for 160min to obtain L-aspartic acid; further purify through a modified cross-linked dextran gel filtration column with a flow rate of 1BV / h to obtain high-purity L-aspartic acid.
[0032] The shaking culture temperature of the shaking table is 36°C and the rotation speed is 160r / min.
[0033] The centrifugal speed is 4600r / min.
[0034] The preparation method of the culture medium is: Dissolve 0.5g yeast powder, 1g peptone and 1g NaCl in 140g pure water, adjust the pH to neutral, and sterilize for later use.
[0035] The preparation method of the fermentation medium is as follows: Dissolve 2g yeast powder, 6g peptone, 2g NaCl, and 2g lactose in 850g pure water, adjust the pH to neutral, and sterilize for later use.
[0036] The preparation process of the modified cross-linked dextran gel in S5 is as follows: First, 60 g of washed cross-linked dextran gel G-75 was taken and placed in a low-temperature plasma treatment device; at this stage, a mixed vapor of mercaptoethanol vapor and nickel acetylacetone vapor was selected as the carrier gas, the gas flow rate was controlled at 35 ml / min, and the power was adjusted to 140 watts. Under such conditions, the gel was plasma treated for 15 minutes; Secondly, a mixed vapor of ammonia, dimethyldiallylammonium chloride and nickel acetylacetonate was introduced, the air flow rate was adjusted to 18 ml / min, and the plasma treatment was continued for 15 minutes; after the treatment was completed, the sample was vacuum dried at 65°C to obtain a modified cross-linked dextran gel.
[0037] The volume ratio of the mixed steam of ammonia and dimethyldiallylammonium chloride is 1:0.3.
[0038] The mixed steam of the mercaptoethanol steam and the nickel acetylacetone steam has a volume ratio of 1:0.02.
[0039] Embodiment 3: The biological production method of L-aspartic acid, its operation steps are: S1: Inoculate the L-aspartate lyase strain into the culture medium and culture it on a shaker for 9 hours as the first generation, and continue to culture the second generation under the same conditions; S2: Transfer the inoculation volume to the fermentation medium at 7% of the volume of the transferred medium, shake and culture for 3 hours, then lower the temperature to 30°C and continue culturing for 7 hours, centrifuge for 8 minutes, discard the supernatant, and obtain the bacterial cells; S3: Take 4 g of the centrifuged bacteria and add 240 g of water to obtain a high-purity bacterial solution; S4: Take 8g of high-purity bacterial liquid, add 8g of sodium alginate and 0.4g of glutaraldehyde, mix well, slowly drip into 18g of CaCl2 solution, react at 35°C for 170min to form gel beads, filter out the beads, wash twice with sodium chloride saline to obtain immobilized cells; S5: Take 0.8g of immobilized cells and 8g of fumaric acid with a mass concentration of 290g / L, adjust the pH to 8, and oscillate on a shaker at a constant temperature for 170min to obtain L-aspartic acid; further purify through a modified cross-linked dextran gel filtration column with a flow rate of 1.5BV / h to obtain high-purity L-aspartic acid.
[0040] The shaking culture temperature of the shaking table is 36°C and the rotation speed is 170r / min.
[0041] The centrifugal speed is 4900r / min.
[0042] The preparation method of the culture medium is: Dissolve 0.8g yeast powder, 1.5g peptone and 1.5g NaCl in 180g pure water, adjust the pH to neutral, and sterilize for later use.
[0043] The preparation method of the fermentation medium is as follows: Dissolve 4g yeast powder, 8g peptone, 4g NaCl and 4g lactose in 950g pure water, adjust the pH to neutral, and sterilize for later use.
[0044] The preparation process of the modified cross-linked dextran gel in S5 is as follows: First, 80 g of washed cross-linked dextran gel G-75 was taken and placed in a low-temperature plasma treatment device; at this stage, a mixed vapor of mercaptoethanol vapor and nickel acetylacetone vapor was selected as the carrier gas, the gas flow rate was controlled at 45 ml / min, and the power was adjusted to 180 watts. Under such conditions, the gel was subjected to plasma treatment for 25 minutes; Secondly, a mixed vapor of ammonia, dimethyldiallylammonium chloride and nickel acetylacetonate was introduced, the air flow rate was adjusted to 23 ml / min, and the plasma treatment was continued for 25 minutes; after the treatment was completed, the sample was vacuum dried at 65°C to obtain a modified cross-linked dextran gel.
[0045] The volume ratio of the mixed steam of ammonia and dimethyldiallylammonium chloride is 1:0.4.
[0046] The mixed steam of the mercaptoethanol steam and the nickel acetylacetone steam has a volume ratio of 1:0.04.
[0047] Embodiment 4: The biological production method of L-aspartic acid, its operation steps are: S1: Inoculate the L-aspartate lyase strain into the culture medium and culture it on a shaker for 10 h as the first generation, and continue to culture the second generation under the same conditions; S2: Transfer the inoculation volume to the fermentation medium at 8% of the volume of the transferred medium, shake and culture for 4 hours, then lower the temperature to 30°C and continue culturing for 8 hours, centrifuge for 10 minutes, discard the supernatant, and obtain the bacterial cells; S3: Take 5 g of the centrifuged bacteria and add 250 g of water to obtain a high-purity bacterial solution; S4: Take 10g of high-purity bacterial liquid, add 10g of sodium alginate and 0.5g of glutaraldehyde, mix well, slowly drip into 20g of CaCl2 solution, react at 40℃ for 180min to form gel beads, filter out the beads, wash twice with sodium chloride saline to obtain immobilized cells; S5: Take 1g of immobilized cells and 10g of fumaric acid with a mass concentration of 300g / L, adjust the pH to 8, and oscillate on a shaker at a constant temperature for 180min to obtain L-aspartic acid; further purify through a modified cross-linked dextran gel filtration column with a flow rate of 2BV / h to obtain high-purity L-aspartic acid.
[0048] The shaking culture temperature of the shaking table is 37°C and the rotation speed is 180r / min.
[0049] The centrifugal speed is 5000r / min.
[0050] The preparation method of the culture medium is: Dissolve 1g yeast powder, 2g peptone and 2g NaCl in 200g pure water, adjust the pH to neutral, and sterilize for later use.
[0051] The preparation method of the fermentation medium is as follows: Dissolve 5g yeast powder, 10g peptone, 5g NaCl, and 5g lactose in 1000g pure water, adjust the pH to neutral, and sterilize for later use.
[0052] The preparation process of the modified cross-linked dextran gel in S5 is as follows: First, 100 g of washed cross-linked dextran gel G-75 was taken and placed in a low-temperature plasma treatment device; at this stage, a mixed vapor of mercaptoethanol vapor and nickel acetylacetone vapor was selected as a carrier gas, the gas flow rate was controlled at 50 ml / min, and the power was adjusted to 200 watts. Under such conditions, the gel was plasma treated for 30 minutes; Secondly, a mixed vapor of ammonia, dimethyldiallylammonium chloride and nickel acetylacetonate was introduced, the air flow rate was adjusted to 25 ml / min, and the plasma treatment was continued for 30 minutes; after the treatment was completed, the sample was vacuum dried at 70°C to obtain a modified cross-linked dextran gel.
[0053] The volume ratio of the mixed steam of ammonia and dimethyldiallylammonium chloride is 1:0.5.
[0054] The mixed steam of the mercaptoethanol steam and the nickel acetylacetone steam has a volume ratio of 1:0.05.
[0055] Comparative Example 1: The cross-linked polysaccharide gel G-75 is not modified, and the rest is the same as in Example 1.
[0056] Comparative Example 2: No dimethyldiallylammonium chloride was added, and the other steps were the same as in Example 1.
[0057] Comparative Example 3: No nickel acetylacetonate was added, and the other conditions were the same as those in Example 1.
[0058] Table 1: Test results of various embodiments and comparative examples
[0059] Through the data analysis of the above examples and comparative examples, the L-aspartic acid prepared by the present invention has high content and high yield.
[0060] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment as above, it is not used to limit the present invention. Any technical personnel in this field can make some changes or modify the technical contents disclosed above into equivalent embodiments without departing from the scope of the technical solution of the present invention. However, any brief modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention are still within the scope of the technical solution of the present invention.
Claims
1. A biological production method for L-aspartic acid, characterized in that: S1: Inoculate the L-aspartate lyase strain into the culture medium and culture it on a shaker for 6-10 hours as the first generation, and continue to culture the second generation under the same conditions; S2: Transfer the inoculation amount to the fermentation medium at 3-8% of the volume of the transferred medium, culture on a shaker for 2-4 hours, then lower the temperature to 30°C and continue culturing for 5-8 hours, centrifuge for 5-10 minutes, discard the supernatant, and obtain the bacterial cells; S3: Take 1-5 portions of the centrifuged bacteria and add 200-250 portions of water to obtain a high-purity bacterial solution; S4: Take 5-10 parts of high-purity bacterial liquid, add 5-10 parts of sodium alginate and 0.1-0.5 parts of glutaraldehyde, mix well, slowly drip into 10-20 parts of CaCl2 solution, react at 30-40°C for 150-180 minutes to form gel beads, filter out the beads, wash twice with sodium chloride saline to obtain immobilized cells; S5: Take 0.1-1 parts of immobilized cells and 5-10 parts of fumaric acid with a mass concentration of 260-300 g / L, adjust the pH to 7-8, and oscillate on a shaker at a constant temperature for 150-180 minutes to obtain L-aspartic acid; further purify through a modified cross-linked dextran gel filtration column with a flow rate of 0.5-2 BV / h to obtain high-purity L-aspartic acid.
2. The biological production method of L-aspartic acid according to claim 1, characterized in that: The shaking culture temperature of the shaking table is 35-37°C and the rotation speed is 150-180r / min.
3. The biological production method of L-aspartic acid according to claim 1, characterized in that: The centrifugal speed is 4500-5000r / min.
4. The biological production method of L-aspartic acid according to claim 1, characterized in that: The preparation method of the culture medium is: Dissolve 0.1-1 parts of yeast powder, 0.2-2 parts of peptone, and 0.2-2 parts of NaCl in 100-200 parts of pure water, adjust the pH to neutral, and sterilize for later use.
5. The biological production method of L-aspartic acid according to claim 1, characterized in that: The preparation method of the fermentation medium is as follows: Dissolve 1-5 parts of yeast powder, 5-10 parts of peptone, 1-5 parts of NaCl, and 1-5 parts of lactose in 800-1000 parts of pure water, adjust the pH to neutral, and sterilize for later use.
6. The biological production method of L-aspartic acid according to claim 1, characterized in that: The preparation process of the modified cross-linked dextran gel in S5 is as follows: First, 40-100 portions of washed cross-linked dextran gel G-75 are taken and placed in a low-temperature plasma treatment device; at this stage, a mixed vapor of mercaptoethanol vapor and nickel acetylacetone vapor is selected as a carrier gas, the gas flow rate is controlled at 30-50 ml / min, and the power is adjusted to 100-200 watts. Under such conditions, the gel is subjected to plasma treatment for 10-30 minutes; Secondly, a mixed vapor of ammonia, dimethyldiallylammonium chloride and nickel acetylacetonate is introduced, the air flow rate is adjusted to 15-25 ml / min, and the plasma treatment is continued for 10-30 minutes; after the treatment is completed, the sample is vacuum dried at 60-70°C to obtain a modified cross-linked dextran gel.
7. The biological production method of L-aspartic acid according to claim 6, characterized in that: The volume ratio of the mixed steam of ammonia and dimethyldiallylammonium chloride is 1:(0.2-0.5).
8. The biological production method of L-aspartic acid according to claim 6, characterized in that: The mixed steam of the mercaptoethanol steam and the nickel acetylacetone steam has a volume ratio of 1:(0.003-0.05).
Citation Information
Patent Citations
L-aspartic acid from fumaric acid - by treatment with aspartase from Bacterium Cadaveris atcc 9760
BE818480A
L-aspartic acid enzymatic conversion preparation method
CN108531525A
